Literature DB >> 23911396

Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures.

Estrid Hein1, Jakob T Bay, Lea Munthe-Fog, Peter Garred.   

Abstract

Ficolin-2 (L-ficolin) is a germ line encoded pattern recognition molecule circulating in the blood, and functions as a recognition molecule in the lectin complement pathway. However, consistent and reliable measurements of Ficolin-2 concentration and activity have been difficult to achieve. After recurrent observations of deviations in Ficolin-2 properties between different blood sample procedures, we decided to investigate this closer. Blood samples from ten healthy donors were collected in various serum and plasma tubes and Ficolin-2 properties were evaluated by different ELISA setups. We found that serum prepared from tubes containing the clot activator silica used as a standard technique in many routine laboratories held a significantly lower concentration of Ficolin-2 as compared to the other sample types. Furthermore, Ficolin-2 binding and complement activation potential in this type of serum was impaired when using an acetylated compound as matrix. On the other hand, Ficolin-2 in serum made without clot activator and in plasma irrespective of additive used, had the same concentration and was capable of initiating the lectin pathway measured as C4 and C3 deposition on the ligand. No Ficolin-2 mediated formation of the terminal complement complex was observed under the applied assay conditions. In conclusion, our results show that Ficolin-2 is a promiscuous molecule and that care should be taken during sampling, handling and matrix chosen for measurement of Ficolin-2 levels and activity.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood sampling; ELISA; Ficolin-2; Ficolin-3 complement; L-ficolin; Lectin pathway; Ligand specificity; MASP; MBL; MBL/ficolin/collectin associated serine protease; Plasma; SPS; Sampling; Serum; Silica; TCC; acBSA; acetylated bovine serum albumin; enzyme linked immunosorbent assay; mannose-binding lectin; sodium polyanethole sulfonate; terminal complement complex

Mesh:

Substances:

Year:  2013        PMID: 23911396     DOI: 10.1016/j.molimm.2013.05.233

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

1.  Lectin pathway factors in patients suffering from juvenile idiopathic arthritis.

Authors:  Katarzyna Kasperkiewicz; Łukasz Eppa; Anna S Świerzko; Marcin A Bartłomiejczyk; Zbigniew M Żuber; Katarzyna Siniewicz-Luzeńczyk; Elżbieta Mężyk; Misao Matsushita; Leokadia Bąk-Romaniszyn; Krzysztof Zeman; Mikael Skurnik; Maciej Cedzyński
Journal:  Immunol Cell Biol       Date:  2017-04-13       Impact factor: 5.126

2.  Blood collection tubes influence serum ficolin-1 and ficolin-2 levels.

Authors:  Allison M Brady; Brady L Spencer; Ann R Falsey; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Lectin complement pathway proteins in healthy individuals.

Authors:  A Troldborg; A Hansen; S W K Hansen; J C Jensenius; K Stengaard-Pedersen; S Thiel
Journal:  Clin Exp Immunol       Date:  2017-01-18       Impact factor: 4.330

4.  Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo.

Authors:  E Hein; L Munthe-Fog; A S Thiara; A E Fiane; T E Mollnes; P Garred
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

5.  Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation.

Authors:  Oskar Eriksson; Joyce Chiu; Philip J Hogg; John P Atkinson; M Kathryn Liszewski; Robert Flaumenhaft; Bruce Furie
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

6.  Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.

Authors:  Michael Osthoff; Gene-Siew Ngian; Melinda M Dean; Mandana Nikpour; Wendy Stevens; Susanna Proudman; Damon P Eisen; Joanne Sahhar
Journal:  Arthritis Res Ther       Date:  2014-11-18       Impact factor: 5.156

7.  A New Ligand-Based Method for Purifying Active Human Plasma-Derived Ficolin-3 Complexes Supports the Phenomenon of Crosstalk between Pattern-Recognition Molecules and Immunoglobulins.

Authors:  Aleksandra Man-Kupisinska; Mateusz Michalski; Anna Maciejewska; Anna S Swierzko; Maciej Cedzynski; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

8.  Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °C.

Authors:  Kimball Aaron Geno; Richard E Kennedy; Patricia Sawyer; Cynthia J Brown; Moon H Nahm
Journal:  PeerJ       Date:  2016-11-17       Impact factor: 2.984

9.  Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults.

Authors:  Anna Sokołowska; Anna S Świerzko; Gabriela Gajek; Aleksandra Gołos; Mateusz Michalski; Mateusz Nowicki; Agnieszka Szala-Poździej; Anna Wolska-Washer; Olga Brzezińska; Agnieszka Wierzbowska; Krzysztof Jamroziak; Marek L Kowalski; Steffen Thiel; Misao Matsushita; Jens C Jensenius; Maciej Cedzyński
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

10.  Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.

Authors:  Severin Vogt; Jörg D Leuppi; Jonas Rutishauser; Michael Osthoff; Philipp Schuetz; Beat Mueller; Carmen Volken; Sarah Dräger; Marten Trendelenburg
Journal:  Respir Res       Date:  2021-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.